Will you consider switching over your Lantus users to Lilly’s new basal insulin Basaglar,
Switching to Basaglar Jan 2, 201612,355 views Share Facebook Twitter LinkedIn Will you consider switching over your Lantus users to Lilly’s new basal insulin Basaglar, which is not approved as a biosimilar product, but has the same exact properties as Lantus and will likely be less expensive? Yes No Not sure View Results Loading ...
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Loading ...